Lupin, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness (NCT03137992) | Lupin, Inc. | 2017-11-21 |
Track Lupin, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.